The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT02037789




Registration number
NCT02037789
Ethics application status
Date submitted
14/01/2014
Date registered
16/01/2014
Date last updated
26/09/2016

Titles & IDs
Public title
A Retrospective Study to Identify New "Omics" Biomarkers of Chronic/Persistent Low Back Pain
Scientific title
A Retrospective Study to Identify New "Omics" Biomarkers of Chronic/Persistent Low Back Pain
Secondary ID [1] 0 0
Pain-OMICS RT
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Persistent/Chronic Low Back Pain 0 0
Condition category
Condition code
Musculoskeletal 0 0 0 0
Other muscular and skeletal disorders
Neurological 0 0 0 0
Other neurological disorders

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
GENETIC OUTCOME
Timepoint [1] 0 0
30 months
Secondary outcome [1] 0 0
GLYCOMIC AND ACTIVOMIC OUTCOME
Timepoint [1] 0 0
30 months
Secondary outcome [2] 0 0
STRATIFICATION OF OUR POPULATION
Timepoint [2] 0 0
30 months

Eligibility
Key inclusion criteria
Inclusion Criteria of patients with persistent CLBP:

- age: older than 18;

- chronic/persistent pain (pain lasting longer than 12 weeks) between the costal margins
and gluteal fold, with or without symptoms into one or both legs

- written informed consent signed;

- Caucasian ancestry

Inclusion Criteria of healthy volunteers:

- age: older than 18;

- without any chronic/persistent pain (pain lasting longer than 12 weeks) in the last
one year;

- written informed consent signed;

- Caucasian ancestry
Minimum age
18 Years
Maximum age
99 Years
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
- evidence of clinically unstable disease;

- severe psychiatric disorder (excluding mild depression) or mental impairment;

- recent history ( < 1 year) of spinal fracture;

- pain in the back due to spinal tumor or infection;

- pregnancy

Study design
Purpose
Duration
Selection
Timing
Retrospective
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
Edith Cowan University (ECU) - Perth
Recruitment postcode(s) [1] 0 0
- Perth
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
North Carolina
Country [2] 0 0
Belgium
State/province [2] 0 0
Genk
Country [3] 0 0
Croatia
State/province [3] 0 0
Zabok
Country [4] 0 0
Italy
State/province [4] 0 0
Parma
Country [5] 0 0
Italy
State/province [5] 0 0
Pavia

Funding & Sponsors
Primary sponsor type
Other
Name
University of Parma
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
GENOS
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Commercial sector/Industry
Name [2] 0 0
Ip Research Consulting Sasu
Address [2] 0 0
Country [2] 0 0
Other collaborator category [3] 0 0
Commercial sector/Industry
Name [3] 0 0
Helmholtz Zentrum München
Address [3] 0 0
Country [3] 0 0
Other collaborator category [4] 0 0
Other
Name [4] 0 0
YURII AULCHENKO
Address [4] 0 0
Country [4] 0 0
Other collaborator category [5] 0 0
Other
Name [5] 0 0
King's College London
Address [5] 0 0
Country [5] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Low back pain (LBP) is one of the most common medical problems encountered in daily life; it
is related to disability and work absence and accounts for high economical costs in Western
societies.

Low-back pain is a diverse group of mixed pain syndromes (neuropathic and nociceptive) with
different molecular pathologies at different structural levels displaying similar clinical
manifestations. Currently, there are limited biomarkers (mostly imaging) or clinical findings
that can be used objectively to help the physician in precise anatomic diagnosis leading to
the safest and most cost-effective treatment for the patient (reduction of direct and
indirect costs and improvement of treatment efficacy).

The main aim of this trial is to identify all "omics biomarkers" associated with
susceptibility to chronic/persistent LBP and its different pathophysiology.
Trial website
https://clinicaltrials.gov/ct2/show/NCT02037789
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
MASSIMO ALLEGRI, MD
Address 0 0
Fondazione IRCCS Policlinico San Matteo di Pavia
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT02037789